Hiroshi Miyamoto, M.D., Ph.D.

Hiroshi Miyamoto, M.D., Ph.D.

Contact Information

University of Rochester Medical Center
School of Medicine and Dentistry
601 Elmwood Ave, Box 626
Rochester, NY 14642

Office: (585) 275-8748
Lab: (585) 275-1739
Administrative: (585) 275-3191
Fax: (585) 273-3637

Research Bio

Dr. Miyamoto's primary research interest includes molecular biology of steroid hormone receptors in genitourinary tumors. Specifically, he has been investigating the role of androgen receptor signals in the development and progression of bladder cancer. Epidemiological and clinical data indicate that men have a substantially higher risk of bladder cancer, and the underlying mechanisms of how androgens regulate bladder tumorigenesis and tumor outgrowth will offer explanations for this gender-specific difference in cancer incidence. He has also assessed the effects of new classes of androgen receptor antagonists on prostate cancer progression and has characterized novel androgen receptor co-regulators in prostate cancer cells.

Awards & Honors (Local)

Johns Hopkins Greenberg Bladder Cancer Research Award 2015 - 2016
Department of Defense Prostate Cancer Research Program Idea Development Award 2013 - Present
Clinical and Translational Science Institute (CTSI) - Laboratory Support Award (LSA) | University of Rochester Medical Center 2012
Department of Defense Prostate Cancer Research Program Physician Research Training Award 2009 - 2015
Department of Defense Breast Cancer Research Program Idea Development Award 2002 - 2005
CaPCURE Award 1997

Recent Journal Articles

Showing the 5 most recent journal articles. 161 available »

2017 Jan 9
Mizushima T, Tirador KA, Miyamoto H. "Androgen receptor activation: A prospective therapeutic target for bladder cancer?" Expert opinion on therapeutic targets. 2017 Jan 9; Epub 2017 Jan 09.
2016 Nov 30
Kawahara T, Sakamaki K, Ito H, Kuroda S, Terao H, Makiyama K, Uemura H, Yao M, Miyamoto H, Matsuzaki J. "Developing a preoperative predictive model for ureteral length for ureteral stent insertion." BMC urology. 2016 Nov 30; 16(1):70. Epub 2016 Nov 30.
2016 Nov 29
Ohtaka M, Kawahara T, Mochizuki T, Takamoto D, Hattori Y, Teranishi JI, Miyoshi Y, Yumura Y, Hasumi H, Yokomizo Y, Hayashi N, Kondo K, Yao M, Miyamoto H, Uemura H. "RANK/RANKL expression in prostate cancer." International journal of surgery case reports. 2016 Nov 29; 30:106-107. Epub 2016 Nov 29.
2016 Nov 8
Miyamoto H. "Clinical benefits of frozen section assessment during urological surgery: Does it contribute to improving surgical margin status and patient outcomes as previously thought?" International journal of urology : official journal of the Japanese Urological Association. 2016 Nov 8; Epub 2016 Nov 08.
2016 Nov
Kashiwagi E, Fujita K, Yamaguchi S, Fushimi H, Ide H, Inoue S, Mizushima T, Reis LO, Sharma R, Netto GJ, Nonomura N, Miyamoto H. "Expression of steroid hormone receptors and its prognostic significance in urothelial carcinoma of the upper urinary tract." Cancer biology & therapy. 2016 Nov; 17(11):1188-1196. Epub 2016 Sep 16.

Current Appointments

Associate Professor - Department of Pathology and Laboratory Medicine (SMD) - Primary
Associate Professor - Department of Urology (SMD)
Associate Professor - Cancer Center


Anatomic Pathology - American Board of Pathology


PhD | Urology | Yokohama City University School of Medicine2000
MD | Medicine | Yokohama City University School of Medicine1988

Post-Doctoral Training & Residency

Fellowship in Urological Pathology at Johns Hopkins University School of Medicine, Office of Registrar07/01/2008 - 06/30/2009
Residency in Pathology at University of Rochester Medical Center07/01/2005 - 06/30/2008
Residency in Urology at Yokohama City University Hospital06/02/1988 - 06/01/1990